Lipid Controls
Cayman Chemical LIPID L-319 25MG
Cayman Chemical | 9-[4-(dimethylamino)-1-oxobutoxy]-heptadecanedioic acid, 1,17-di-(2Z)-2-nonen-1-yl ester| 25 mg | 35051 | Purity: ≥95% | 1351586-50-9
Cayman Chemical KOdiA-PC | 439904-33-3 | MFCD12912356 | 10mg
KOdiA-PC | Purity: ≥98% | MW: 663.8 | 439904-33-3 | MFCD12912356 | 10mg
Cayman Chemical ALC-0315 | 2036272-55-4 | MFCD33402175 | 25 mg
ALC-0315 | Purity: ≥98% | Mol Wt: 766.3 | 2036272-55-4 | MFCD33402175 | 25 mg
Cayman Chemical SM-102, CC-33474-100
SM-102 is a cationic lipid used for transfection and formulation of nucleic acid-based therapeutics. It is supplied as a solution in ethanol at 10 mg/mL concentration by Bionordika. Some key features of SM-102 include its ability to form small and stable nucleic acid-containing nanoparticles, enable effective cytosolic delivery and endosomal escape of nucleic acids, and exhibit low toxicity. SM-102 is compatible with various nucleic acid payloads including mRNA, siRNA, and DNA. The 100 mg quantity is sufficient for formulating 10 mL of 10 mg/mL liposomes. SM-102 can facilitate effective delivery of nucleic acid therapeutics in vitro and in vivo.
Cayman Chemical SM-102 | 2089251-47-6 | MFCD34167521 | 250 mg
SM-102 | Purity: ≥98% | Mol Wt: 710.2 | 2089251-47-6 | MFCD34167521 | 250 mg
Cayman Chemical ALC-0315 | 2036272-55-4 | MFCD33402175 | 100 mg
ALC-0315 | Purity: ≥98% | Mol Wt: 766.3 | 2036272-55-4 | MFCD33402175 | 100 mg
Cayman Chemical 15-keto Prostaglandin E1, 22973-19-9, 5 mg
15-keto PGE1 is the inactive metabolite of PGE1 produced by 15-hydroxy PGDH. It has greatly diminished biological activity compared to PGE1.{4165,4168}